Deccan Transcon Leasing Limited (NSE:DECCANTRAN)
India · Delayed Price · Currency is INR 31.75
-0.70 (-2.16%)
At close: Aug 1, 2025
Regulus Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Net Income | 61.84 | 118.19 | 85.57 | 51.91 | 29.71 | Upgrade |
Depreciation & Amortization | 18.44 | 18.19 | 13.24 | 11.65 | 9.59 | Upgrade |
Other Amortization | - | 0.25 | 0.4 | 0.34 | 0.57 | Upgrade |
Loss (Gain) From Sale of Assets | - | 0.58 | 0.62 | -0.01 | -0.05 | Upgrade |
Loss (Gain) on Equity Investments | -13.56 | - | - | - | - | Upgrade |
Other Operating Activities | 25.43 | 33.32 | 26.25 | 13.23 | 12.03 | Upgrade |
Change in Accounts Receivable | -263.26 | -160.74 | -51.59 | -7.4 | 47.61 | Upgrade |
Change in Accounts Payable | -0.25 | 10.84 | -44.17 | -44.44 | -70.69 | Upgrade |
Change in Other Net Operating Assets | 16.48 | 14.73 | 1.4 | 16.78 | 3.12 | Upgrade |
Operating Cash Flow | -154.89 | 35.37 | 37.17 | 49.51 | 31.89 | Upgrade |
Operating Cash Flow Growth | - | -4.84% | -24.92% | 55.24% | - | Upgrade |
Capital Expenditures | -430.14 | -69.19 | -56.18 | -30.35 | -8.8 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.49 | Upgrade |
Investment in Securities | 1.72 | -12.82 | -14.43 | -1.85 | -4.98 | Upgrade |
Other Investing Activities | 2.94 | 0.62 | 0.44 | 0.16 | -0.71 | Upgrade |
Investing Cash Flow | -425.48 | -81.4 | -70.16 | -32.04 | -14 | Upgrade |
Short-Term Debt Issued | - | 20.53 | 68.62 | 12.74 | - | Upgrade |
Long-Term Debt Issued | 95.43 | 32.88 | 9.95 | - | - | Upgrade |
Total Debt Issued | 95.43 | 53.41 | 78.57 | 12.74 | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -9.32 | -16.4 | Upgrade |
Net Debt Issued (Repaid) | 95.43 | 53.41 | 78.57 | 3.43 | -16.4 | Upgrade |
Issuance of Common Stock | 522.41 | 22.45 | - | 2 | 3.47 | Upgrade |
Other Financing Activities | -25 | -34.3 | -21.24 | -17.55 | -10.62 | Upgrade |
Financing Cash Flow | 592.84 | 41.56 | 57.33 | -12.13 | -23.54 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | -0 | - | 0 | - | Upgrade |
Net Cash Flow | 12.48 | -4.47 | 24.34 | 5.34 | -5.66 | Upgrade |
Free Cash Flow | -585.03 | -33.82 | -19.01 | 19.16 | 23.09 | Upgrade |
Free Cash Flow Growth | - | - | - | -17.02% | - | Upgrade |
Free Cash Flow Margin | -35.18% | -2.22% | -1.06% | 1.25% | 2.52% | Upgrade |
Free Cash Flow Per Share | -29.14 | -1.97 | -1.13 | 1.14 | 1.77 | Upgrade |
Cash Interest Paid | 25 | 30.74 | 18.63 | 13.38 | 10.62 | Upgrade |
Cash Income Tax Paid | 10.11 | 33.64 | 21.47 | 14.37 | 7.4 | Upgrade |
Levered Free Cash Flow | -619.68 | -119.43 | -77.81 | -12.51 | 9.1 | Upgrade |
Unlevered Free Cash Flow | -604.05 | -101.07 | -67.75 | -5.45 | 15.28 | Upgrade |
Change in Net Working Capital | 243.4 | 156.17 | 93.02 | 36.88 | 19.59 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.